BLFS three-lens brief
Evidence-based stock research on BLFS. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
50-day MA above 200-day MA (golden-cross regime); price above both. · Analyst mean target $31.29 — 10% below current (7 analysts).
- 50-day MA above 200-day MA (golden-cross regime); price above both.
- Analyst mean target $31.29 — 10% below current (7 analysts).
BLFS closed at $34.92 (-0.03%) as of 2026-09-11. Market cap: $1.71B. P/E (trailing) 34.9. Price is above the 50-day MA and above the 200-day MA. Positives: 50-day MA above 200-day MA (golden-cross regime); price above both.. Concerns: analyst mean target $31.29 — 10% below current (7 analysts).. Last quarter: Revenue $28.47M, net income $45.10M, free cash flow $4.66M.
Why three lenses on BLFS, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BLFSacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/BLFS" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BLFS brief"></iframe>